Long-term administration of CTLA4Ig prevents the onset of disease in systemic lupus erythematosusCprone (SLE-prone) NZB/NZW F1 mice. plasma cells in the bone tissue marrow, both which are much less reliant on T-cell help, seem to be unaffected by CTLA4Ig. High-dose CTLA4Ig didn’t induce long lasting tolerance within this autoimmune disease model. Furthermore, however the mice… Continue reading Long-term administration of CTLA4Ig prevents the onset of disease in systemic